Growth Metrics

NovoCure (NVCR) Receivables - Net (2016 - 2026)

NovoCure's Receivables - Net history spans 13 years, with the latest figure at $53.1 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 56.07% to $53.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $53.1 million, a 56.07% increase, with the full-year FY2025 number at $58.7 million, up 67.32% from a year prior.
  • Receivables - Net hit $53.1 million in Q1 2026 for NovoCure, down from $58.7 million in the prior quarter.
  • Over the last five years, Receivables - Net for NVCR hit a ceiling of $101.0 million in Q1 2022 and a floor of $17.5 million in Q3 2022.
  • Historically, Receivables - Net has averaged $56.1 million across 5 years, with a median of $58.7 million in 2025.
  • Biggest five-year swings in Receivables - Net: skyrocketed 443.65% in 2022 and later plummeted 71.3% in 2024.
  • Tracing NVCR's Receivables - Net over 5 years: stood at $26.0 million in 2022, then decreased by 12.64% to $22.7 million in 2023, then skyrocketed by 54.62% to $35.1 million in 2024, then surged by 67.32% to $58.7 million in 2025, then decreased by 9.44% to $53.1 million in 2026.
  • Business Quant data shows Receivables - Net for NVCR at $53.1 million in Q1 2026, $58.7 million in Q4 2025, and $85.2 million in Q3 2025.